A 15-Yr prospective histological follow-up study in patients with persistently normal aminotransferase levels (PNAL) carrying HCV infection [5]

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2604-2606

  Rossi, Sonia ^a   De Filippi, Francesca ^a   Saibeni, Simone ^a   Persico, Marcello ^b   Bollani, Simona ^a   Camera, Angelica ^a   Rizzolo, Laura ^a   Croce, Anna Maria ^a   Bruno, Savino ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT;

AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; COURSE EVALUATION; DISEASE CARRIER; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFECTION RISK; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MALE; MANDATORY TESTING; PERSISTENT INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 35449008390     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01514_5.x     Document Type: Letter

References (9)

1. Puoti C, Castellacci R, Montagnese F, et al. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: The Italian prospective study of the asymptomatic C carriers (ISACC). J Hepatol 2002 37 : 117 23.
2. Martinot-Peignoux M, Bayer N, Cazals-Hatem D, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 2001 34 : 1000 5.
3. Persico M, Persico E, Suozzo R, et al. Natural history of hepatitis C virus carrier with persistently normal aminotransferase levels. Gastroenterol 2000 118 : 760 4.
4. Okanoue T, Makiyama A, Nakayama M, et al. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase. J Hepatol 2005 43 : 599 605.
5. Bruno S, Rossi S, Petroni ML, et al. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994 308 : 697.
6. Colloredo Mels G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003 39 : 239 44.
7. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 9.
8. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 349 : 825 32.
9. Rumi MG, De Filippi F, Donato MF, et al. Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough. J Viral Hep 2002 9 : 71 74.